Salud y sistemas de salud
How one novel treatment can tackle dangerous, 'hard-to-kill' bacteria
Researchers have developed a novel combination therapy using the anticancer agent mitoxantrone (MTX), together with an antibiotic, vancomycin, for treating bacteria that are resistant to ...